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Tendon-to-bone interface (enthesis) exhibits a complex multi-scale architectural and 
compositional organization maintained by a heterogeneous cellular environment. 
Orthopedic surgeons have been facing several challenges when treating tendon pullout or 
tear from the bony insertion due to unsatisfactory surgical outcomes and high re-tear 
rates. The limited understanding of enthesis hinders the development of new treatment 
options toward enhancing regeneration. Mimicking the natural tissue structure and 
composition is still a major challenge to be overcome. In this review, we critically assess 
current tendon-to-bone interface tissue engineering strategies through the use of 
biological, biochemical or biophysical cues, which must be ultimately combined into 
sophisticated gradient systems. Cellular strategies are described, focusing on cell sources 
and co-cultures to emulate a physiological heterotypic niche, as well as hypoxic 
environments, alongside with growth factor delivery and the use of platelet-rich 
hemoderivatives. Biomaterials design considerations are revisited, highlighting recent 
progresses in tendon-to-bone scaffolds. Mechanical loading is addressed to uncover 
prospective engineering advances. Finally, research challenges and translational aspects 
are considered. In summary, we highlight the importance of deeply investigating enthesis 
biology toward establishing foundational expertise and integrate cues from the native 
niche into novel biomaterial engineering, aiming at moving today’s research advances into 



















































































































































































































































The main goal of this review is to give an overview of cell-based and tissue engineered 
strategies for tendon-to-bone interface. The essential role of cells in tendon-to-bone 
interface development, healing, and regeneration, is underpinned by the physiological 
status of the junction. Therefore, recent studies underlining the effect of oxygen 
concentration and production of growth factors are reviewed. A critical view is made on 
the use of two-dimensional versus three-dimensional culture systems and mechanical 
stimulation. An overview of advances on bioengineered strategies in light of the 
biological/cellular requirements of enthesis will contribute to innovations in tendon-to-
bone engineering and regeneration.  
Keywords: 2D vs 3D culture, cell-based strategies; Gradient Biomaterials; Growth factors; 


















































































































































































































































Table of contents 
1. Introduction 
2. Multi-scale structural and compositional organization 
3. Cell-based strategies  
 3.1. General considerations 
 3.2. Cell sources: From stem cells to differentiated cells 
 3.3. Co-culture systems 
  3.3.1.  Co-cultures using terminally differentiated cells 
  3.3.2. Co-culture of terminally differentiated cells with stem cells 
  3.3.3. Co-cultures using biomaterials 
3.4. Hypoxic environment 
3.5. Growth factors 
4. Two- or three-dimensional (2D/3D): a biomaterials approach 
 4.1. 2D nanofiber-based materials 
 4.2. 3D bio-instructive scaffolds 
5. Static or dynamic? The role of mechanical stimulation 
6. Clinical translation 


















































































































































































































































1. Introduction  
Soft-to-hard tissue interfaces, such as tendon-to-bone insertions, are compelled to deal 
with large mismatch mechanical needs of two widely different tissues and, therefore, 
known to be under increased failure chances. Orthopedic surgeons frequently face the 
challenge of torn enthesis (tendon/ligament-to-bone interface), partial or complete 
rupture of tendons and ligaments and bone avulsions. Statistically, 20%-80% of the general 
population above 50 to 80 years has been diagnosed with a rotator cuff tear [1]. Similarly, 
younger patients are affected by acute or overuse sports injuries, such as tennis and 
golfer’s elbow, jumper’s knee and Achilles insertional tendinopathies [2,3]. Nevertheless, 
the enthesis can also be affected by extrinsic and intrinsic factors (such as trauma, 
systemic illness, age-related degeneration or pharmacotherapy) resulting in general 
insertional disorders, known as enthesopathies, and/or enthesitis, if an inflammatory 
process is involved [4]. Current methods to manage enthesis pathologies include, in a first 
approach, conservative treatments (e.g., rest, mechanical conditioning, corticosteroids 
injection, orthotics, among others) normally with limited success, or surgical interventions 
through the routine application of grafts (auto-, allo- and synthetic grafts). However, 
surgical repair still presents several major problems, including tissue harvesting, host 
tissue reaction, risk of disease transmission, slow or lack of tissue integration and donor 
tissue availability [5,6]. Additionally, following repair, grafts are associated with high 
recurrence rates due to formation of neo-fibrovascular tissue, compromising the stability 
and consequently mechanical performance of the newly formed tissue [6,7]. As a result, 
high probability of re-injury, deformation, pull-out and long rehabilitation periods are 
associated with these common surgical procedures [6,8]. Thus, given the importance of 
this interface within the skeleton and all the clinical challenges concerning its repair, there 
is a crucial need to regenerate this critical soft-to-hard tissue transition.  
In the past decades, a new field of tissue engineering has arisen, called interfacial tissue 
engineering, aiming at the recreation of complex and hierarchical interfacial tissues in 
order to repair or to regenerate diseased or damaged junctions [9]. Many attempts have 
been made to improve the repair and ultimately regenerate the enthesis, but challenges 

















































































































































































































































as replicating the spatial distribution of signaling factors and cellular interactions, which 
are essential for a normal interfacial function and homeostasis [10,11]. A variety of 
interdependent tissue engineered strategies have been proposed over the years [12–14] 
and can be roughly grouped into four connected categories: (1) scaffold-based strategies, 
(2) cell-based strategies, (3) growth factors and gene therapy and, finally, (4) mechanical 
stimulation. However, up to now, the existing challenges faced in the clinics, when trying 
to restore musculoskeletal interfaces functionality, including graft laxity and inferior 
mechanical properties associated with a lack in the identification of appropriate healing 
factors and time of administration at the repair site, have led to a preference toward stem 
cell-mediated treatments, due to their regenerative and differentiation potential as Nature 
tissue engineers. As cells are the major players in orchestrating tissue regeneration, this 
review will discuss current cell-based strategies with and without biomaterial constructs 
for tendon-to-bone repair. In light of this, cellular/biological, biochemical and biophysical 
components (Figure 1) will be discussed. Instead of extensively analyzing currently 
explored strategies, this review intends to collect insights illustrating the usefulness of cell-
based approaches and highlight main challenges and prospective successes. 
2. Multi-scale structural and compositional organization 
The enthesis is a musculoskeletal structure that allows a smooth transition between two 
widely different tissues, displaying a gradient in composition, tissue organization and, 
therefore, mechanical properties. Hence, this interface displays a unique 
microenvironment, which maintains specific cellular phenotypes throughout different 
localizations within the tissue, playing an important role in its composition, maintenance 
and regeneration. A close look reveals a well-organized structure with spatiotemporal 
distribution of extracellular proteins and biochemical signals produced by distinct cell 
populations that work in synchrony to enable the biological function of the whole tissue.  
The most commonly found enthesis, denominated as fibrocartilogenous, is described as a 
four-divided zone structure (Figure 2). Firstly, the tendinous part is composed by collagen 
type I, proteoglycans, decorin and biglycan, being populated by tendon cells aligned in the 

















































































































































































































































demonstrated a ~500 m zone where tendon crimped fibers unravel into smoother and 
thinner interface fibers before attaching to bone [16] (Figure 3). This small area is 
constituted by two distinct zones, the unmineralized and mineralized fibrocartilage. The 
unmineralized zone is populated by fibrochondrocytes that are responsible for ECM 
production of collagens type I and II, together with aggrecan [17]. Interestingly, mineral 
deposition and calcification starts at the mineralized fibrocartilage with a clearly visible 
straight line, called as tidemark, that delimitates the true transition between mineralized 
and unmineralized tissue [18]. The mineralized fibrocartilage consists of collagens type II 
and X and aggrecan produced by resident hypertrophic chondrocytes. Finally, the fourth 
zone corresponds to bone, which is constituted by a dense mineralized collagen type I 
matrix populated by bone cells (osteoblasts, osteoclasts, osteocytes).  
Overall, besides matrix mineralization increase along the interface, a gradient in collagen 
fibers orientation is observed from the tendon (fiber alignment) to bone. This allows the 
mitigation at the interface of stress concentrations [19]. Moreover, the collagen fibrils 
mineral arrangement, either extrafibrillar or intrafibrillar, leads to a controlled and graded 
increase of stiffness, resulting in a smooth load transfer [20].  
Interestingly, the fibrocartilogenious insertion is regarded as avascular and aneural 
recalling the nature of articular cartilage [21], which can be explained by the levels of 
compression it is subjected to or by the presence of aggrecan, known by its axonal growth 
inhibitory effect in the nervous system [22]. However, tissue microdamage is very common 
to occur and appears to be responsible for vessel ingrowth, thus leading to immune cells 
infiltration and the onset of inflammatory events [23]. Moreover, the presence of vessels 
and nerve ingrowth have been also reported in enthesis of elderly human Achilles tendons 
as a consequence of degenerative changes [24]. Therefore, altered vascularity may provide 
an anatomic explanation for enthesis-related diseases and damage. Additionally, many 
fibrocartilage sites present fat pad near the insertion site which, in combination with the 
bursa, serve to promote frictionless movements [25,26], being this movements 
compromised in patients with entheseal degenerative diseases [25,26]. Nevertheless, fat 

















































































































































































































































changes in the insertional angle, immune function due to its rich macrophage population 
and source of pain in enthesopathies [21]. 
When trying to mimic the native tissue, one of the major challenges is the replication of all 
the structural features of the enthesis, as well as meeting the specific requirements for 
each cell type. Although tendon and bone exhibit their own cellular niche and cell 
populations, cells residing at the enthesis present distinctive features. Up to now, there 
are no single cell RNA sequencing studies for enthesis cell populations, thus the 
heterogenicity of resident cells is still poorly understood. Nonetheless, integration of 
transcriptomics and proteomics data has recently shown that enthesis cells express 
cartilage-related markers, including aggrecan, chondroadherin, collagen type II and 
versican, and markers of terminally differentiated hyperthophic chondrocytes, such as 
runt-related transcription factor 2 (RUNX2), integrin binding sialoprotein (IBSP) and matrix 
metallopeptidase 13 (MMP13), suggesting a chondrocyte-like phenotype [15,16]. 
Therefore it is important to develop tissue engineered constructs that not only support the 
deposition and formation of compositionally different tissues in an organized, continuous 
and graded manner but also sustain a spatially-varying cellular content, which play a 
critical role in orchestrating the formation and repair of interfacial tissues.  
3. Cell-based strategies  
3.1. General considerations 
Cell-based strategies for tendon-to-bone interface face some challenges due to the 
complexity of the cellular environment, tissue vascularization and oxygen tension, and 
different mechanical requirements associated with the distinct tissues.  
The search for a single cell source or the use of mixed cultures along with the 
determination of adequate cell ratios are being explored. In particular, the use of co-
cultured cells has shown promising outcomes while trying to overcome the limitations 
associated with the mimicry of the heterotypic communications occurring within the 
native junction. However, many challenges still have to be addressed before stem cells, or 

















































































































































































































































clinics. There is still a real need to evaluate the efficacy of cells and cell-based products in 
long-term safety and well controlled tendon-to-bone healing animal models. Therewithal, 
it is important to have in mind that, even though evidences show a substancial 
development in cell-based therapies and these are recognized as new biotechnological 
innovations, the translation to the clinical environment still faces very strict and complex 
global regulatory issues [27]. 
In the following sections, recent advances regarding cell- and culture-based strategies for 
tendon-to-bone regeneration will be further illustrated and discussed in detail.  
3.2. Cell sources: From stem cells to terminally differentiated cells 
Stem cells, normally from mesenchymal origin, are widely used in interfacial tissue 
engineering. These cells can be isolated from a wide number of human tissues (including 
bone, tendon, cartilage, ligament, adipose, synovial), have self-replication capability and 
are able to differentiate toward mature cells of different lineages such as tendon, bone 
and cartilage [28]. Several studies have demonstrated an improvement in tendon-to-bone 
healing and mechanical properties after transplantation of bone marrow mesenchymal 
stem cells (BMSCs)  [29–31]. Still, other stem cell sources have been exploited for tendon-
to-bone healing, mainly in animal models.  
An interesting example is the emerging use of anterior cruciate ligament (ACL)-derived 
stem cells. These cells have been isolated from ACL and exhibit stem cell properties, such 
as clonogenecity, self-renewal and multidifferentiation capability [32]. Recently, ACL-
derived CD34+ stem cells were identified in injured ACL tissues, displaying higher expansion 
and multidifferentiation potential [33]. The efficacy of these cells has been tested on 
tendon-to-bone healing. Injections of adult human ACL-derived CD34+ stem cells into nude 
mice after ACL reconstruction resulted in an increased number of fibrocartilage cells, 
enhanced angiogenesis and osteogenesis in the presence of CD34+ cells and non-sorted 
cells in comparison with control groups (PBS and CD34- groups) and similar failure load as 
uninjured ACL [34]. However, migration of cells to other tissues was reported. 
Alternatively, the use of cell sheet technology by incorporating ACL-derived CD34+ in a cell 

















































































































































































































































reconstruction and recovery [35].  This strategy resulted in ex vivo gradual cell migration 
within grafted tendon and bone tunnel site, as well as in vivo promotion of angiogenesis 
and osteogenesis, together with accelerated early remodeling observed by the faster 
recovery time, graft maturation and biochemical strength [35].  
Tendon-derived stem cells (TDSCs) have also demonstrated great potential to form 
enthesis-like tissues, alone or in the presence of a carrier. In vivo studies, including 
treatment with bone morphogenetic protein (BMP)-2 and subcutaneous transplantation in 
immunocompromised mice [36] or even incorporation in knitted silk-collagen sponge 
scaffold for rotator cuff regeneration in a rabbit model [37], led to improved mechanical 
and structural properties in comparison with controls and possible formation of a 
osteotendinous-like tissue [36,37]. Even though TDSCs and ACL-derived stem cells seem to 
constitute promising cell types for  tendon-to-bone junction regeneration, donor site 
morbidity, cell number and the need for long expansion periods together with consequent 
phenotypic drift are still a limiting factor for future clinical applications [38]. Furthermore, 
the impracticality of isolating these stem cell populations for further exogenous 
applications still poses a limiting step owing to the need for invasive collection procedures. 
Alternatively, synovial mesenchymal stem cells (sMSCs) and periosteum-derived stem cells 
(PDSCs) have been reported in the literature as reliable cell populations for tendon-to-
bone healing  [39–41]. Although there is still a limited number of studies, some 
encouraging outcomes have been reported. For example,  in vivo injection of sMSCs in a 
bone tunnel enhanced the production of collagen fibers and Sharpey’s fibers between 
tendon and bone [41]. However, after 4 weeks, bone and tendon were attached together, 
without the presence of sMSCs or the formation of a fibrocartilage transition region [41]. 
In this case, even though these cells have shown an effective potential to improve tissue 
healing, they failed in the regeneration of the proper tissue. On the other hand, PDSCs are 
progenitor cells found in the inner layer of the periosteum with the capability to 
differentiate, under appropriate stimulus, toward de chondrogenic and osteogenic 
lineages [42,43]. The combination of these cells along with the appropriate stimulus, e.g. 
growth factors, has been applied to enhance tendon-to-bone healing. Injectable hydrogels 

















































































































































































































































an enhanced tendon-to-bone healing at 8 weeks postoperatively through the formation of 
fibrocartilage in a rabbit rotator cuff healing model [39]. More recently, PDSCs cell sheets 
were evaluated in a rabbit extra-articular bone tunnel model. Results demonstrated 
enhanced deposition of collagen and glycosaminoglycans with fibrocartilage formation at 4 
weeks postoperatively, showing the promising application of periosteum-derived cells 
monolayer in tendon-to-bone healing [40]. But the question still remains in the isolation 
method and either or not a mixture of cells is obtained from the different layers of the 
periosteum, and in the limited differentiation capability demonstrated by clonal cultures of 
periosteum-derived cells [44]. 
A well-known alternative is the use of adipose-derived stem cells (ASCs). This stem cell 
population is more readily accessible from adipose tissue through a minimally invasive 
method, providing higher yield and lower morbidity and pain, as well as higher 
proliferation rate and lower senescence upon in vitro expansion  [45]. Recent studies have 
also demonstrated the feasibility of using ASCs and ASCs subpopulations for the 
generation of tendon- [46–48], bone- [49–51] and cartilage-like tissues [52–54] and the 
potential use of ASCs for tendon-to-bone regeneration has been under study [55–59]. A 
recent report by Kosaka et al. [58], where ASCs were locally injected in a rabbit ACL 
reconstruction model, demonstrated a temporal improvement of tendon-to-bone 
integration with the appearance of a more organized and cartilaginous-like tissue in the 
ASCs-treated group, accompanied by a significantly better failure load 2 and 4 weeks after 
surgery, in comparison to controls  [58]. Additionally, ASCs multilineage differentiation 
potential has been also demonstrated after seeding onto a micropore surface of a porous 
membrane with a dual reverse gradient of growth factors concentrations (PDGF-BB 
gradient from the left to right side of the membrane and BMP-2 gradient from the right to 
left side) to generate a tendon-to-bone like construct [57]. This strategy allowed a 
spatially-modulated differentiation of ASCs toward tenogenic and osteogenic lineages 
according to the gradient of growth factor concentration along the construct. 
Rather than applying a multipotent cell source, the interposition of chondrocytes between 
two tissues (tendon and bone) to mimic the cellular environment found in the native 

















































































































































































































































model, Wong et al. investigated the use of an allogeneic chondrocyte pellet in restoring 
the transitional fibrocartilage and tendon-to-bone healing, demonstrating an early 
integration and formation of a fibrocartilage-like zone, without immune rejection, 
suggesting a possible stimulatory effect of these cells [60]. Comparably, Nourissat et al. 
[61] studied the ability of chondrocytes to restore the normal function of tendon-to-bone 
while comparing it with the ability of BMSCs. An Achilles tendon repair model was induced 
in rats by destroying the enthesis; afterwards chondrocytes and BMSCs were injected and 
the healing rate, tissue remodelling and biomechanical load were assessed [61]. The 
injection of both cell types resulted in the production of enthesis-like tissue as soon as 15 
days, which was not observed in control groups (not injected rats) [61]. However, only 
MSCs-injected were able to recapitulate the enthesis organization with columnar 
chondrocytes as observed in uninjured tissues [61]. Nonetheless, the ability of 
chondrocytes to improve tendon-to-bone healing is still relatively unexplored. 
As said before, several cell sources are being explored to restore the normal function of 
tendon-to-bone interface through the improvement of fibrocartilage formation and 
enhancement of mechanical properties. The use of stem cells for tendon-to-bone interface 
tissue engineering presents several advantages compared to terminally differentiated 
cells. Multipotent stem cells can be expanded until a sufficient number for transplantation 
is achieved, whereas terminally differentiated cells present limited expansion, and can be 
induced to differentiate into the distinct phenotypes found at the enthesis. Moreover, a 
lack of immunological reaction, together with their capability to “empower” other cell 
types residing at the injured tissue makes them an optimal option while trying to be 
incorporated in vivo.  
3.3. Co-culture systems 
The use of novel multi-cell type co-culture systems can substantially facilitate the 
formation of transition regions of the tendon-to-bone interface, while giving better 
insights about the developmental process of enthesis insertion site.  
Generally, culture systems can be divided in two-dimensional (2D) or 3D [62]. Particularly, 

















































































































































































































































(Figure 1). Direct contact co-cultures are based on cell-cell interactions, paracellular 
diffusion of paracrine factors and also cell-ECM communication [62]. On the other hand, in 
indirect contact or noncontact co-cultures, cells are separated by a porous membrane 
(normally a transwell), thus only the culture medium is shared, allowing the study of 
paracrine interactions between different cell populations [62]. Other approaches are 
based on conditioned media from one type of cells that can be used to culture other type 
of cells, and even the use of decellularized matrices [63]. These strategies can be applied 
to assess the effect of paracrine factors without the need of pre-labelling the different cell 
populations [63]. In interface tissue engineering, usually two types of strategies are 
applied: co-culture of terminally differentiated cells and co-culture of terminally 
differentiated cells with stem cells [62]. Table 1 highlights main outcomes regarding 2D 
and 3D co-culture systems for tendon-to-bone tissue engineering and regenerative 
medicine applications. 
The role of stem cells in these systems goes beyond their multidifferentiation capacity. 
Normally, in co-cultures, stem cells are the target cells to differentiate and eventually 
synthetize ECM or metabolites favorable to a tissue. The employment of co-cultures using 
terminally differentiated cells with stem cells underwent significant advances in the last 
years. However, even though exogenous factors are applied to induce a more controlled 
cellular response, the crosstalk between the different cell types turns this phenomena 
more complex than it was initially believed. Therefore, novel co-culture strategies based 
on the manipulation of the in vitro supplementation to modulate the communication 
occurring between these cell types is of major importance.  
3.3.1. Co-cultures using terminally differentiated cells 
In the field of tendon-to-bone tissue engineering, there are few studies reporting the use 
of co-culture systems for tendon-to-bone regeneration. Wang et al. [64] studied the 
interactions occurring between osteoblasts and ligament fibroblasts using a direct contact 
co-culture model. Primary osteoblasts and fibroblasts, obtained from trabecular bone 
fragments and ACL, respectively, were first seeded using 1:1 ratio in a tissue culture plate 

















































































































































































































































removed, allowing cells to migrate and interact directly (Figure 4 A-B). Cells were pre-
labelled to control cell migration and subsequent interactions. After 14 days, three regions 
could be distinguished: fibroblasts, fibroblasts plus osteoblasts (interface) and osteoblasts 
[64], demonstrating the effectiveness of direct cell-cell physical contact in the 
establishment of different regions. ALP activity and mineralization by fibroblasts seemed 
to be influenced by the presence of osteoblasts, suggesting that osteoblast–fibroblast 
interactions may lead to fibroblasts trans-differentiation [64] (Figure 4 C-E). Furthermore, 
at the gene level, an up-regulation of collagen type II, aggrecan and cartilage-oligomeric 
protein (COMP), interface-relevant markers, was observed in the interface region, in 
comparison with the regions containing only osteoblasts or fibroblasts [64]. Despite these 
interesting results regarding the expression of interface-related markers, using only 
terminally differentiated cells was not proven to be sufficient to trigger the formation of 
an interface-like region in vitro [64]. Interestingly, another approach by Cooper et al. [65] 
demonstrated the importance of medium supplementation for an appropriate matrix 
deposition in a multiphased co-culture setup. In this case, cell lines of NIH 3T3 fibroblasts 
and MC 3T3 osteoblasts were used and the medium supplemented with 3mM 
betaglycerophosphate and 25µg/mL ascorbic acid to reduce fibroblasts mineralization 
while enhancing the osteoblasts response.  
Overall, co-culture studies using terminally differentiated cells can represent simplified in 
vitro models of native tissue physiology. Altogether, these results have shown that the 
crosstalk between fibroblasts and osteoblasts, representing tendon and bone cellular 
environments, respectively, can induce phenotypic alterations, particularly through 
fibroblast mineralization. Nonetheless, this constitutes a less controlled response given 
that these systems frequently require the use of cell-specific conditions or additional 
supplementation, challenging tissue engineering protocols. 
3.3.2. Co-culture of terminally differentiated cells with stem cells  
Alternatively to the sole use of differentiated cells, the crosstalk between these and stem 
cells has been increasingly exploited under the rationale that the intricate communication 

















































































































































































































































phenotypes. In turn, stem cells are expected to contribute with key signaling molecules, 
“empowering” native cell populations. In this context, a tri-culture model has been 
developed using primary fibroblasts and osteoblasts in combination with BMSCs; cells 
were seeded in opposing sides of the tissue culture well and fibroblasts or BMSCs 
embedded in an agarose-gel and placed in the middle region of the plate, allowing for 
individual analysis [66]. Additionally, the effect of fibroblasts-osteoblasts physical contact 
on BMSCs differentiation was studied using a mixture of fibroblasts-osteoblasts (1:1 ratio) 
in both sides of the agarose gel, resulting in three different regions: fibroblasts-
osteoblasts, BMSCs and fibroblasts-osteoblasts [66]. Interestingly, in contrast to 
fibroblasts, BMSCs in tri-culture were found to express interface-relevant markers (such as 
proteoglycans, as well as collagen types I and II at the gene level) throughout time in 
culture [66]. Matrix mineralization potential was reduced, but BMSCs exhibited higher ALP 
activity in comparison with fibrochondrocytes and fibroblasts; and, in contrast to ALP 
activity in tri-culture, the highest ALP activity was delayed in time suggesting an enzyme 
suppression, resulting from osteoblasts-fibroblasts interaction [66]. Moreover, gene 
expression of SOX9, collagen type II and production of proteoglycans was significantly up-
regulated in the mixed tri-culture demonstrating an important role of cell-cell 
communication in BMSCs differentiation toward fibrochondrogenic phenotype [66]. 
Together, these results support the hypothesis that the direct crosstalk between 
differentiated and stem cells within the system can potentiate fibrochondrogenic 
commitment characteristic of the chondrocyte-like phenotype observed for native 
enthesis cells [15]. Furthermore, conditioned media from parallel cultures of  fibroblasts-
only, osteoblasts-only, and fibroblast-osteoblast co-culture were collected and added to 
monocultures of BMSCs to evaluate the effect of paracrine communication  [66]. Strikingly, 
glycosaminoglycan deposition was reduced when BMSCs were exposed to conditioned 
media from co-culture of fibroblasts and osteoblasts. The same decrease was observed in 
BMSCs proliferation and ALP activity in the presence of both osteoblast- and fibroblast-
conditioned media [66]. Overall, fibroblasts-osteoblasts direct interactions seem to play an 

















































































































































































































































Additionally, the use of mixed culture media in co-cultures of human tendon-derived cells 
(hTDCs) and pre-osteoblasts (pre-OBs, osteogenically induced ASCs) has been studied to 
assess medium composition influence on the expression of tendon-, bone- and interface-
related markers  [67]. An intermediate condition of 1:1 ratio of basal medium and 
osteogenic medium was reported as optimal for the maintenance of tenogenic and 
osteogenic phenotypes in single cultures of hTDCs and pre-OBs, respectively [67]. A direct 
co-culture model with hTDCs and pre-OBs (1:1 cell ratio) was then established. 
Interestingly, the presence of osteogenic medium seemed to increase the expression of 
bone-related markers (osteopontin, SPP1, and Runt-related transcription factor 2, RUNX2) 
in comparison with pre-OBs expression levels, suggesting the existence of a bi-directional 
cellular communication. Moreover, the expression of interface-relevant markers 
(aggrecan, ACAN, and COMP) was also increased in comparison with single cultures, 
suggesting a possible targeting toward chondrogenesis [67].  
Altogether, the effect of medium supplementation and cell-cell interations played an 
important role on the modulation of cells phenotype with future application in more 
complex systems to promote the formation of a enthesis-like tissue. These results 
constitute promising outcomes in light of recent descriptions of enthesis cells phenotype, 
which resemble chondrocyte-like cells [15,16] and the use of an optimal culture condition 
that can maintain different phenotypes at the same time is a major advantage supporting 
the combination of stem cells with differentiated cells. 
3.3.3. Co-cultures using biomaterials 
The development of scaffold-based strategies along with the use of co-cultures has been 
also explored to overcome the structural complexity of tendon-to-bone junction. A 
biomimetic continuous triphasic scaffold was designed aiming at the regeneration of ACL-
to-bone interface, consisting of three phases: phase A (soft tissue) formed from polyglactin 
10:90 knitted mesh sheets; phase B (interface) made from poly(D-L-lactide-coglycolide) 
(PLGA) 85:15 copolymer microspheres; and phase C (hard tissue) comprised of composite 
microspheres consisting of a 4:1 ratio of PLGA and 45S5 bioactive glass [68]. Human 

















































































































































































































































extremities of the scaffold and allowed to migrate during culture time. Cell tracking results 
showed that fibroblasts adhered to phase A and osteoblasts to phase C, and cells 
continuously proliferated, resulting in  fibroblast-osteoblast interaction within phase B  
[68]. Higher ALP activity and mineralization were mainly restricted to phase C, confirming 
the osteoconductivity effect of this phase provided by the bioactive glass, while higher 
amounts of collagen type I were observed in the presence of fibroblasts in phase A, 
together with a controlled phase-specific distribution of ECM over time [68]. 
Unfortunately, the expression of fibrocartilage-related markers was not assessed in the 
interface region, limiting the interpretation of in vitro cellular crosstalk effects alone. 
Notwithstanding, in vivo implantation studies of this multi-phasic scaffold tri-cultured with 
fibroblasts, chondrocytes and osteoblasts were performed to evaluate the formation of a 
fibrocartilage-like structure [69]. Three experimental groups were considered: tri-cultured, 
co-cultured (fibroblasts and osteoblasts only) and acellular scaffolds. Seeded scaffolds 
were cultured for 4 days prior to implantation and implanted subcutaneously in rats for 8 
weeks. Immunohistological stainings demonstrated the deposition of collagenous-rich 
matrix in all phases of the scaffold in co- and tri-cultures, in opposition to acellular 
scaffolds, with collagen type III majorly found in phase A [69]. Moreover, tissues mineral 
distribution by micro-CT confirmed the mineralization confinement in phase C in all 
experimental groups [69]. Interestingly, the presence of a tri-culture led to an enhanced 
degradation of phase A, resulting in the formation of a fibrocartilage-like region revealed 
by the presence of collagen types I, II and X [69].  
Another relevant approach is the combination of stem cells, terminally differentiated cells 
and scaffolds. For ligament-bone regeneration, He et al. [70] used knitted silk scaffolds tri-
cultured with rabbit BMSCs, fibroblasts and osteoblasts. Separate scaffolds were firstly 
seeded individually and cultured for 7 days; the three parts were then knitted together 
and a scaffold composed of 5 distinct regions (osteoblasts only, BMSCs plus osteoblasts, 
BMSCs only, BMSCs plus fibroblasts and fibroblasts only) was obtained. A gradual 
transition was formed from the region where BMSCs directly interacted with fibroblasts to 

















































































































































































































































differentiate toward the fibrocartilage lineage, exhibiting at gene level an up-regulation of 
collagen type II, SOX9 and aggrecan in comparison with monocultures of BMSCs [70]. 
Altogether, these results anticipate the potential of controlling cellular interactions while 
changing scaffolds porosity, architecture and composition which allowed selective cell 
ingrowth, stimulating the production of a heterogeneous cell matrix along the scaffold 
and, therefore, the generation of a gradual transition between a soft and hard tissue. 
Overall, the combination of co-cultures with scaffold design constitutes a multidisciplinary 
approach for studying possible cell-cell and cell-matrix interactions occurring in the native 
tissue. 
Even tough co-cultures are presented as important in vitro cell culture methodologies, 
there is still a lack of understanding regarding the mechanisms governing tendon-to-bone 
interface development and regeneration. Therefore, further studies should first focus on 
the characterization of important cellular interactions while using co- or tri-cultures, as a 
relevant in vitro platform to mimic as close as possible the cellular environment found at 
tendon-to-bone interface. 
3.4. Hypoxic environment  
Oxygen concentration is an important signal for the development and maintenance of 
several tissues. Tendon-to-bone interface presents a “critical zone” near the proximal 
tendon/bone attachment, poorly vascularized, where the oxygen supply is very low. 
Similarly, tendons are also poorly vascularized tissues [72,73] while, in contrast, bone is 
highly vascularized [74]. Oxygen concentrations ranging from 5.5% to 15% have been 
estimated in bone tissue [75–77]. In contrast, as muscles oxygen tension varies between 
3.6-4.0%, tendon oxygen saturation falls below this value [78,79]. This is corroborated by 
the quantification of oxygen consumption in tendons (5.3%/min) and muscles (10.5%/min) 
during rest [80,81]. Over the past years, studies have been focusing on the effect of 
hypoxia on tenogenic [82–84], chondrogenic [85–88] and osteogenic [88–92] 
differentiation of stem cells. Interestingly, in vitro studies comparing different oxygen 
tensions, revealed distinct cell responses. For instance, human tendon-derived stem cells 

















































































































































































































































proliferation and increased number of colonies in comparison with cells maintained under 
normoxia (20-21% oxygen) [82–84]. The multilineage differentiation capability of this cell 
population seemed to be influenced by a myriad of oxygen concentrations (20%, 10%, 5%, 
2%, 0.5%) both in vitro and in vivo [82–84]. Indeed, when expanded in vitro at 5% O2 and 
afterwards implanted in vivo using an engineered tendon matrix, cells expressed 
osteogenic-, adipogenic- and chondrogenic- markers, such as osteocalcin, adiponectin, 
collagen type II, respectively, even though in lower levels compared to cells maintained at 
20% O2 prior in vivo implantation (control) [82]. Interestingly, these cells were found to be 
more prone to express tenogenic-markers, such as collagen type I, than the correspondent 
controls [82]. In contrast, this phenotypic commitment seemed to be inhibited in in vitro 
cultures maintained under lower oxygen concentrations (0.5-2% O2) [83,84]. 
Moreover, the influence of hypoxia in an indirect co-culture using tenocytes and ASCs was 
also studied to get deeper in the potential effect of oxygen concentration and paracrine 
factors on tenogenic differentiation of ASCs [93]. The expression of hypoxia-inducible 
factor-1 alpha (HIF-1α) was analyzed and, under hypoxic conditions, it seemed to play an 
important role in the differentiation of ASCs toward the tenogenic phenotype. Indeed, 
after HIF-1α inhibition, gene expression of collagen type I and III, tenomodulin, 
thrombospondin-4 and scleraxis, relevant tenogenic markers, was significantly inhibited in 
comparison with the control group, suggesting a potential role of HIF-1α on ASCs 
tenogenic differentiation under hypoxia [93]. Similarly, low oxygen tensions (1, 3, 5, and 
10% O2 concentration) seemed to have a negative effect on the osteogenic differentiation 
of human stem cells, given that a reduction in the expression of osteogenic-related 
markers, such as RUNX2, matrix mineralization and ALP activity has been described 
[89,94–96]. Likewise, at 2% O2 concentration, murine ASCs exhibited decreased 
chondrogenic and osteogenic potential, in comparison with cells cultured under normoxia 
[97]. Intringuingly, some reports in the literature have shown an enhancement of 
osteogenic differentiation of human and rat BMSCs under hypoxic conditions (1% and 5%). 
In both cases, low oxygen concentrations influenced BMSCs migration, enhancing cell 
attachment and survival, accompanied by increased cell proliferation, matrix 

















































































































































































































































level, human BMSCs expressed higher levels of osteocalcin and osteopontin, while, in 
constrast chrondogenic- (COMP and aggrecan) and adipogenic-related (adipsin, FASN) 
markers levels were significantly reduced [98]. Collectively, the lack of standardized cell 
isolation methods, experimental parameters, stem cells source and different oxygen 
concentrations contribute to the challenge inherent to the determination of the role of 
oxygen in stem cells differentiation. 
Notwithstanding, an interesting phenomenon was the influence of 2D and 3D cultures 
under hypoxic condition observed in human ASCs. In the presence of 1%-5% O2 tension, 
ASCs presented a downregulation in the expression of osteogenic markers (ALP activity, 
mineralization and gene expression of RUNX2, collagen type 1, alpha chain 1 (COL1A1) and 
bone gamma-carboxyglutamate   [gla] protein or osteocalcin (Bglap)) in both 2D and 3D 
cultures, even though osteogenic differentiation in 2D was clearly more enhanced in 
comparison with 3D cultures [91]. However, differences in the osteogenic markers 
revealed a temporal change under different oxygen conditions. The expression of collagen 
type I was higher under 21% oxygen environment in 3D cultures than in 2D, increasing up 
to week 2, but even though 5% and 1% displayed lower expression levels, at each time 
point the expression was similar to that observed in 2D [91]. Moreover, in contrast with 
TDSCs, ASCs showed an independent HIF-1α inhibition of osteogenic differentiation, 
observed by a downregulation of osteogenic markers in both 1% and 2% oxygen in 2D and 
3D cultures [100]. 
Therefore, oxygen variations in the culture environment seem to play an important role in 
stem cell fate. Hence, it is of major importance to have in mind the gradual heterotypic 
cellular environment that is found in tendon-to-bone interface. Future approaches should 
not only focus on the individual oxygen concentration found in tendon and bone but come 
up with a balanced concentration to support the tenogenic, chondrogenic and osteogenic 




















































































































































































































































3.5. Growth factors 
Growth factors also play an important role in the repair and development of a functional 
tissue as regulators of cell differentiation, proliferation and matrix deposition [101]. 
Interestingly, during tendon-to-bone healing process, a temporal expression of several 
growth factors seems to occur, as reported by different enthesis repair in vivo studies 
(Table 2). Therefore, the best time for growth factors delivery must be studied since it can 
potentiate the effectiveness of future treatments. Moreover, the correct combination of 
growth factors or the most effective growth factor must also be determined. 
In a first approach, several in vitro studies have been focusing on the optimization of cell 
culture medium supplementation. Bone morphogenetic protein (BMP)-2 [102], BMP-7 
[103,104] and transforming growth factor (TGF)-β3 [105] are some examples of relevant 
growth factors used for medium supplementation that affect cell behavior in vitro. 
Supplementation with BMP-7 was tested in a co-culture model of murine osteoblasts and 
fibroblasts cell lines; agarose dividers were used for two days and BMP-7 added at three 
different concentrations (100, 250 or 500 ng/mL) [104]. BMP-7 supplementation resulted 
in a suppression of Spp1 (osteopontin) expression at the osteoblast region, while up-
regulating alkaline phosphatase (ALPL) and COL1A1, as well as, BGLAP and RUNX2 at the 
interface region; on the fibroblast region, Alpl, Bglap and Runx2 were highly expressed 
[104]. Interestingly, the presence of BMP-7 seemed to influence Col1A1 expression in all 
the regions, suggesting a possible increase in ECM formation and maturation [104]. In a 
similar study, Thomopoulos et al. [105] reported the importance of growth factor 
supplementation using tensile cyclic and compressive stresses for rat MSC differentiation 
in the presence and absence of TGF-β3. Actually, it was clearly observed that Sox9 and 
aggrecan were only expressed by cells maintained with medium supplemented with TGF-
β3, in constrast with cells only maintaned under influence of tensile and compressive 
stress [105]. Indeed, medium supplementation seems to play an important role in cell 
behavior. Thus, it is imperative to study the possible synergistic effects that may occur 

















































































































































































































































Another important challenge that must be overcome is the study and development of 
sustained-release vehicles for growth factor delivery. An interesting approach for a 
continuous and stable release of growth factors was introduced by gene therapy based on 
stem cells. This genetic intervention has shown promising results in comparison with the 
direct administration of growth factors to promote tendon-to-bone healing. Autologous 
MSCs transfected with platelet-derived growth factor-B (PDGF-B) [106], BMP-2 [107–109], 
TGF-β [110]  and the combination of two different growth factors [111] genes have been 
reported in the literature for tendon-to-bone healing. Even though, transfected stem cells 
secrete several growth factors in a steadily and continuous way, a decrease of the growth 
factor with time may lead to a loss of the primary objective after several weeks. Moreover, 
in vivo application involves delivering the vector directly into the cells of the tissue, which 
can lead to uncontrollable side effects, such as mutagenesis or development of malignancy 
[112,113]. Instead, the use of biomaterials has been alternatively exploited for the 
controlled delivery of growth factors envisioning tendon-to-bone healing. Most of the 
reported literature is focused on in vivo studies to assess the influence of growth factors 
during different stages of tendon-to-bone healing. These studies use different gels, 
cements and glues for the local delivery of growth factors. Such systems overcome several 
limitations associated to bolus injections of growth factors, including rapid leakage, short 
half-life of soluble factors, denaturation, injection risks and the use of supraphysiological 
dosages. However, for example, rotator cuff surgeries are performed by arthroscopic 
surgery, therefore involving the placement trough cannulas, making the previous vehicles 
less appropriate and desired in comparison with scaffolds and patches. Diverse animal 
injury and repair models have been developed and overall, the presence of growth factors 
appear to increase the cellularity and tissue quality at the injury site. Table 3 summarizes 
the major outcomes obtained in these studies.  
More recently, blood derivatives have been receiving increased attention as cost-effective 
sources of human therapeutic factors that can be used in both autologous and allogeneic 
applications in regenerative medicine  [114]. There is a wide range of platelet containing 
products with different biological characteristics, including platelet-rich plasma (PRP), 

















































































































































































































































derivatives for enthesis repair and regeneration is frequently investigated, either in the 
form of soluble preparations or gels. Table 4 summarizes the major outcomes of in vivo 
studies applying PRP preparations to enthesis healing models. In general, studies on PRP 
administration demonstrate conflicting results with some studies presenting improved 
tissue healing through enhanced cellular response and mechanical performance, while 
others report no differences in tissue healing response. Furthermore, clinical reports have 
demonstrated conflicting outcomes, including mid-term positive outcomes upon rotator 
cuff tendinopathy treatment using multiple PRP injections, but no differences in tissue 
integrity [117] or on re-tear rate [118]. Although contradictory results have been 
frequently found, the use of blood derivatives other than PRP in in vitro settings has been 
gaining attention to modulate cell behaviour, particularly for tendon tissue engineering 
(TTE). Indeed, PL can be a more stable alternative since it shows a comparatively lower 
batch-to-batch variability in batches prepared from platelet concentrates of different 
donors [119], potentially resulting in more predicatable clinical outcomes. Although no 
studies exist concerning the application of PL preparations for enthesis repair, PL 
membranes have been reported to result in an up-regulation of tenogenic genes and 
deposition of tendon-related ECM proteins by hTDCs [120]. Furthermore, nanocomposite 
hydrogels based on PL have been reported to modulate the behavior of ASCs according to 
nanofillers content [121], suggesting prospective applications for the development of 
gradient tissue engineered constructs in vitro. 
Overall, studies have shown that several growth factors have the ability to increase the 
“quality” of repaired tissues in animal models. Given the complexity of tendon-to-bone 
interface, tissue repair is most probably orchestrated by a multitude of growth factors 
released in a temporally and spatially controlled manner. Hence, it has become clear that 
the application of multiple growth factors may be needed to regenerate the insertion site 
between tendon and bone. However, parameters such as optimal delivery time and 
vehicle are not effective. Although the use of growth factor gradients is being explored for 
providing adequate biochemical cues [12], this strategy can only be explored in 

















































































































































































































































Even though, growth factor therapy remains an important therapeutic for tendon-to-bone 
healing and regeneration and needs to be further exploited in light of the discussed 
current limitations. 
4. Two- or three-dimensional (2D/3D): a biomaterials approach 
In vitro 2D culture systems are an oversimplified version of the human physiological 
conditions [158]. Indeed, shifting from 2D to 3D has a significant impact on cell 
proliferation, differentiation, survival and mechanical response. Novel 3D cell culture 
approaches were developed to mimic as close as possible the in vivo complex interactions 
of tissues and organs, opening new possibilities to study both biochemical and 
biomechanical signals [159]. Particularly, interfacial tissue engineering has put efforts to 
develop structures that mimic the anisotropic structural properties observed in interface 
tissues, such as the one found in tendon-to-bone interface. Therefore, biomimetic 
scaffolds with graded morphology/architecture, topography and composition are useful, 
especially when physical and chemical factors affect the fate of cultured cells in 3D 
scaffolds in a spatially orchestrated manner. interfacial tissue engineering is going beyond 
the production of multi-phasic scaffolds with the fabrication of graded biomaterials, 
capable of mimicking the gradual transition of interface tissues while supporting both 
heterotypic and homeotypic cell-cell interactions and cell-matrix integration. Common 
approaches include the fabrication of aligned nanofibers scaffolds with the incorporation 
of mineral gradients [160–163], scaffolds with gradations in fiber organization [163–165],  
bi- and tri-phasic scaffolds [68,71,166,167] and graded hydrogels [56,168,169].  
4.1. 2D nanofiber-based materials 
Conventional eletrospinning process has evolved during the last years. Even though there 
is a pressing need for the development of 3D structures, approaches using 2D environment 
have demonstrated to be useful in mimicking the nanostructure and composition of 
tendon-to-bone junction. One interesting approach for 2D nanofibers was developed 
applying a 2-spinnerette device to create a nonwoven mat of PCL nanofibers containing a 
gradient of amorphous calcium phosphate nanoparticles (nACP). Here, increasing nACP 

















































































































































































































































along the gradient, which suggested that the presence of nACP potentiated the adhesion 
and proliferation of osteoblasts [160]. Similarly, a nonwoven mat of electrospun PCL 
nanofibers was developed and submersed in 10 times concentrated simulated body fluid 
(SBF) solution to create a calcium phosphate gradient, resulting in an increase of Young’s 
modulus [161], mimicking the spatially graded mineral composition and mechanics of 
enthesis. Likewise, Liu et al. [162] developed aligned PLGA electrospun mats with a similar 
SBF mineral gradient and also demonstrated the ability to spatially control the 
differentiation of a single stem cell source. Indeed, ASCs exhibited increased ALP activity, 
as well as Runx2 and OCN expression, indicating that osteogenic differentiation of ASCs 
was attained along the increasing mineral concentration on the scaffold [162]. 
Supplementation with growth factors has also been used as a potential approach for 
tendon-to-bone regeneration. Interestingly, Perikamana et al. [59] focused on the spatially 
combinatory effect of a matrix-bound growth factor (platelet-derived growth factor, 
PDGF), matrix alignment and calcium deposition to mimic tendon-to-bone regeneration in 
an in vitro system. Briefly, random-aligned-random poly(lactic acid) (PLLA) nanofibers 
meshes were produced and PDGF immobilized using an asymmetrical polydopamine 
gradient. Using a precision syringe pump infusion method, the extremities of the nanofiber 
meshes were immersed in SBF solution creating a gradient of mineral deposition in both 
margins. After seeding of ASCs, higher  adhesion, ALP activity and osteogenic gene levels 
were observed in the both ends of the nanofibers meshes in comparison with the middle 
region (unmineralized zone) which lacked mineral deposition [59]. However, no results 
were shown concerning the tenogenic commitment of ASCs when in contact with the 
middle part of the nanofiber mesh where the immobilization took place. 
Understanding the development of the nano-scale structure of tendon-to-bone interface 
may provide novel insights for the improvement of repair strategies. However, even 
though, biological evidences have shown the possible use of nanofibers to induce a 
spatially controlled cell differentiation on eletrospun scaffolds, structures with 3D 
orientations mimicking the proper tissue are an upcoming topic in the fabrication of 

















































































































































































































































4.2. 3D bio-instructive scaffolds 
Remarkably, a 3D scaffold for bone-ligament applications was developed by coating the 
random part of PCL nanofibers with 5x SBF on a “random-aligned-random” scaffold 
structure [170]. Using two spin cones eletrospinning design, non-aligned nanofibers were 
obtained, while the gap in between consisted mainly in aligned fibers, resulting in the 
generation of a transitional zone [170]. Higher ultimate tensile strength, tensile modulus 
and strain at break were observed in the aligned region in comparison with the random 
regions [170]. Scaffolds were then seeded with human BMSCs, which aligned following the 
direction of fibers alignment, with more spindle shaped cells at the aligned part and 
polygonal or round shaped cells in the random regions of the scaffold [170]. Moreover, 
through gene expression analysis, tendon-related markers (tenomodulin and mohawk) 
were found to be up-regulated in the aligned region in comparison with the random and 
mineralized regions, where bone-related markers (runx-2, osteocalcin and osteopontin) 
were highly expressed [170]. Therefore, both chemical and structural characteristics of the 
scaffold seemed to influence the phenotype of hBMSCs toward tenogenic and osteogenic 
lineages. Another approach to obtain a 3D cylindrical composite scaffold was developed 
using an eletrospinning set-up with a dual-drum collector [171]. Two spinnerets were used 
in a first approach to form a single transition zone, and a 3-spinnerets design was 
afterwards used to create two transition regions, while shields were placed in the dual 
drum to control the size of the transition regions [171]. The obtained 2D meshes of PCL 
and PLGA were cut into small pieces, rolled around a guide (20G needle) and withdran and 
bathed in 20% polyethylene glycol diacrylate (PEGDA) solution and PEGDA/Irgacure 2959 
solution, respectively; the needle was removed afterwards originating a 3D cylindrical 
composite scaffold [171]. Mechanical testing was perfomed for both 2D meshes and 3D 
scaffolds, showing that 3D cylindrical composites were more mechanically robust but 
failed due to the stress concentration on the aligned region of the scaffold while 2D 
meshes presented the opposite mechanical behviour [171]; however, the biological 
behavior of cells in contact with the 3D composites was not assessed in this study. 
Multi-phasic scaffolds have been also improving on the gradual transition between 

















































































































































































































































For example, Tellado et al. [166] fabricated biphasic silk fibroin scaffolds with anisotropic 
and isotropic porous alignment, by directional freezing and salt leaching, to mimic the 
gradient in collagen molecule alignment found in tendon-to-bone interface. Aligned 
porosity represented the tendon/ligament side, while random porosity was designed for 
the bone side [166]. Young’s modulus varied along the construct and culture with hASCs 
clearly demonstrated the cytoskeleton organization according to pore alignment [166]. 
Moreover, changes in gene expression of tendon, enthesis and cartilage markers in the 
different regions of the scaffold were observed. In this regard, Sox9 was more expressed in 
the isotropic region of the scaffold and Scx in the anisotropic part, suggesting the potential 
gradual cell differentiation to the chondrogenic and tenogenic lineages along the scaffold 
[166]. 
Up to now, efforts have been concentrated on the developemnt of 3D scaffods which 
replicate either the multi-structural alignment of the interface, the spatially mineral 
distribution or mechanical stimulation to drive cells differentiation to the different 
lineages. However, the conjugation of all factors to create bio-intructive scaffolds would be 
of great matter as demonstrated by Caliari et al. [172] through the development of an 
osteotendinous biomaterial based on a collagen-GAG (CG) scaffold platform. Using freeze-
drying method a CG scaffold was created mimicking the gradients of mineralization with 
calcium phosphate and geometric anisotropy which allowed, within a unique 3D 
biomaterial, to control the spatially selective tenogenic and osteogenic stem cells 
differentiation [172] (Figure 5). Moreover, uniaxial tensile strain was also found to 
specifically guide along the scaffold the MSCs differentiation thoughout the 
osteotendinous lineages [172]. 
New material designs for tendon-to-bone regeneration are also focused on the use of 
hydrogel gradient systems. Hydrogels present tunable chemical and physical properties 
suitable for tailoring the 3D cellular microenvironment. Therefore, the generation of 
biochemical and physical gradients within a hydrogel has become an attractive tool to 
generate a graded tissue. The development of hydrogels with spatially controlled 
patterning of cells has been explored for co-culturing different cell types [56,173]. 

















































































































































































































































fumarate:poly(ethylene glycol)-diacrylate hydrogel-based scaffold for long-term 3D co-
culture of primary tendon fibroblasts and BMSCs, showing their viability up to 2 weeks 
[173]. Additionally, hydrogels as magnetic-responsive materials have been also developed 
as a way to provide structures with the ability to modulate the biochemical, physical and 
mechanical properties of the surrounding tissues. For example, a magnetic-responsive 
hydrogel composed of methacrylated chondroitin sulfate (MA-CS) enriched with platelet-
lysate (PL) was developed to encapsulate osteogenically differentiated human adipose-
derived stem cells (O-ASC) or hTDCs within distinct hydrogel compartments [56]. Swelling, 
degradation and release of growth factors were modulated by the application of an 
external magnetic field (EMF), showing impact on both cell morphology and the expression 
of tendon- (decorin) and bone-related (osteopontin) genes in the different sections of the 
hydrogel after EMF application [56].  
Textile techniques have been also used to produce more complex 3D structures. Knitting 
and braiding are some examples of textile assembly that have been applied to produce 
scaffolds and showed great similarity with, for example, tendons considering its 
architectural features, mechanical properties, and biological functionality [174,175]. 
Interestingly, these techniques have been used to produce knitted silk scaffolds for ACL 
regeneration [176–178]. However, these scaffolds were still unable to be competent and 
did not complety reproduce the structural integrity and functionality of the proper tissue. 
Current advances in the development of 3D biomaterials with a combination of 
compositional, architectural and topographical properties allow the control over cell 
behavior without the need for external supplementation in all dimensions. Collectively, it 
is evident that scaffold topographies and composition influence both the morphology and 
differentiation capability of cells. However, several features still need to be optimized and 
further research of in vitro and in vivo effects on cell behavior could generate new insights 
to achieve a perfectely functional regenerated tissue. Nonetheless, the complexity of 
tendon-to-bone insertion, as well as of other musculoskeletal interfaces, requires the 
coordination between such systems and more complex and controllable factors, including 

















































































































































































































































5. Static or dynamic? The role of mechanical stimulation  
There is still limited knowledge on the material properties of tendon-to-bone interface and 
the specific demands to achieve its full repair and regeneration. During developmental 
stage, biophysical cues influence the development of tendon, bone and cartilage [179–
183]. First evidences were described in cortical bone with numerous studies 
demonstrating the importance of stress environment on the architecture of trabecular 
bone and thickness of cortical bone [184,185]. Similarly, a comparable responsiveness was 
demonstrated on tendon, where the total removal of load led to structural and 
compositional changes and a fast deterioration of tendon strength [186]. Indeed, all cells 
found along tendon-to-bone interface are known to be mechanoresponsive, thus 
mechanobiology is expected to play an important role in the development and healing of 
this tissue interface. Several studies have shown the importance of mechanical loading in 
the development of enthesis in murine models. In a study by Galatz et al. [187], the effect 
of the mechanical environment was evaluated by paralyzing the supraspinatus muscle in a 
rat model of rotator cuff injury and repair. The complete removal of load and 
immobilization clearly had a detrimental effect on rotator cuff healing, in comparison with 
rats with free range of motion, in which structural properties increased and modest 
improvements in biomechanical properties were observed [187]. The role of muscular 
loading in the development of tendon-to-bone interface has been described using a 
murine shoulder model [188,189]. Intramuscular injections of botulinum toxin A or 
laceration were used to paralyze rotator cuff muscles in postnatal mice and saline-
injections were used as controls [188,189]. Diminished muscle loading led to a reduction in 
mineral deposition and deficient fibrocartilage formation, with disorganized fiber 
distribution and inferior tendon mechanical properties at the enthesis [188,189]. In the 
absence of mechanical loading, a decrease in bone volume and a change in bone 
architecture were also noticed [188,189]. Interestingly, the effect of muscle loading did not 
seem to be necessary for initiating enthesis development; however, the signal from 
tendons has an important effect, whereas mechanical loading has an impact on growth 
and maturation of enthesis [188–192]. Hence, it is evident that mechanical loading 

















































































































































































































































to a gradation in mechanical properties along the enthesis, enabling an efficient load 
transfer and reduced stress concentration [10,193].  
Normally, interfacial tissue engineered strategies are based on dynamic cultures to better 
mimic the human physiology in an organ-specific context. For this purpose, bioreactors 
have been designed to spatially control biomechanical and physical signals to guide cell 
proliferation, differentiation and, ultimately, tissue formation [194–198], with the 
application of uniaxial tensile loads and dynamic compressive loading to emulate tendon 
and bone mechanophysiology, respectively. Using this concept, MSCs have been 
differentiated in several scaffolds under the influence of different biomechanical stimuli 
provided in bioreactors [199–202]. Several strategies have focused on the use of diffusing-
based bioreactors to co-differentiate cells along a unique platform creating an interface 
[197,203,204], but, no studies are still available with the use of these dynamic plataforms 
for tendon-to-bone interface. Instead, static cell cultures are commonly used to study the 
developmental stage and mechanical loading influence on tendon-to-bone development 
and healing is often disregarded. Therefore, the development of bioreactors for enthesis 
engineering is a major need, due to the advantageous application of such dynamic systems 
to create a graded interface along a single unit while controlling the environment, 
presenting some advantageous characteristics over the currently used in vitro cultures.  
Finer spatial control should also be focused to enhance knowledge on the effect of several 
chemical stimulus and, therefore, improving local cellular modulation and control. 
6. Clinical translation 
Clinical translation of in vivo results is still a very slow process even though there is 
growing evidence of the benefits of cell-based therapies in tendon-to-bone healing. Few 
victories have been also observed in the clinics using scaffolds for human enthesis repair. 
Many preclinical devices, such as interpositional grafting [205] and rotator cuff 
augmentation [206,207], have failed to restore the normal function of the tissue due to 
inadequate mechanical forces and structural properties of the grafts. Moreover, variations 
between small and larger tears in some follow up studies makes comparisons impossible 

















































































































































































































































rotator cuff and ACL augmentation, not properly restoring the interface. For example, 
porcine small-intestinal submucosa (SIS) patches such as Restore™ SIS (DePuy Orthopedics, 
West Chester, PA, USA) were implanted in 62 patients with rotator cuff tear characteristics 
[210]. An evaluation after 1 year did not reveal significant differences in strength and 
motion between patients treated with SIS and non-treated groups [210]. Similarly, Iannotti 
et al. [211] tested Restore™ SIS in human rotator cuff repair and found inferior tendon 
healing accompanied of increasing pain, thus not recommending the use of these patches 
for augmentating massive chronic rotator cuff tears [211]. Contrarily, GraftJacket (Wright 
Medical Arlington, TN, USA), made from a human cadaveric dermis ECM scaffold, 
demonstrated significant improvements in pain scores, forward flexion, external rotation 
strength with full incorporation of the graft as observed by Bond et al. [51] and Burkhead  
et al. [212]. But, overall these technologies fail when mechanical properties are tested, 
suggesting limited mechanical performance of existing biological scaffolds for rotator cuff 
augmentation. 
Interestingly, few clinical studies investigated the use of stem cells in enthesis healing or 
regeneration. However, once more studies focused solely on tendon/ligament repair when 
targeting interface regeneration and functional recovery. For example,  Hernigou  et al. 
[213] evaluated the efficiency of biological augmentation of rotator cuff repair with iliac 
MSCs in forty-five patients for a period of 10 years and a significant improvement of 
tendon integrity with lower levels of re-tear was observed while using concentrates 
containing MSCs. More recently, in a cohort study, among 182 patients treated through 
arthroscopic surgery for a rotator cuff tear, 35 received an injection of ASCs loaded in 
fibrin glue [214]. In contrast to the previous study, no differences were found between the 
conventional repaired group and the injection group with respect to the internal rotation 
at the back and the functional measures of the constant score and final follow-up [214]. 
Nonetheless, a higher re-tear rate was observed in the conventional group in comparison 
with the injection group, even though no clinical differences were found in the follow-up 
[214].  
Despite the promising results of these clinical therapies, achieving regeneration of tendon-

















































































































































































































































including understading the differences in cellular responses between acute and chronic 
injuries along with the identification of the best strategies. Overall, current clinical 
outcomes support the need for more refined tissue engineering strategies that should 
integrate the complexity of this interface. Furthermore, the knowledge gap regarding the 
molecular characterization of resident cell populations, as mentioned above, has been 
limiting the understanding of cellular differentiation strategies and the evaluation of 
bioengineered strategies effectiveness. Hence, it is of utmost importance to investigate 
deeper the biology of these tissues toward establishing foundational expertise, aiming at 
moving today’s research advances into tomorrow’s regenerative therapies. 
7. Conclusions/ Future trends 
Despite biotechnological advances of  tissue engineering, it is well-recognized that there is 
still a critical need to understand the development and healing of tendon-to-bone 
interface. Over the years, tissue engineers have been trying to replicate the complexity of 
different tissues by attempting to understand the signals involved in the initiation of 
regenerative processes. However, the field of tendon-to-bone biology is lagging far behind 
owing to the peculiarities of this multi-tissue transition. We highlighted that it is of major 
importance to understand the heterotypic cellular interactions occurring in the native 
tissues, particularly the role of cell-cell and cell-ECM contacts and production of paracrine 
factors, for the development of a functional tissue. Co-culture systems have been 
increasingly exploited as platforms to study bidirectional communication. Although 
disparities on selection of cell sources and culture conditions have been hampering the 
establishment of an optimal in vitro system, stem cells of mesenchymal origin have been 
gaining increasing attention for the generation of bioengineered strategies, overcoming 
main limitations of tissue-specific cell populations. In vitro studies using differentiated cells 
and stem cells have been opening new avenues toward understanding the crosstalk 
between distinct cell types in directing pro-regenerative responses, either by stem cell 
differentiation or through synergistic effects in promoting fibrocartilage-like phenotype. 
Furthermore, given the mechanical nature of tendon-to-bone interface, (bio)physical 
elements are postulated to be needed in combination with cellular therapies. Different 

















































































































































































































































properties can be tuned through different fabrication strategies to emulate structural, 
architectural and topographical signals of native interfacial tissue. Nonetheless, the 
application of adequate mechanical signals requires refinement and efforts should be 
focused on understanding the mechanical interplay and its implications on biological 
functions toward the development of sophisticated platforms to support the development 
of functional and physiologically relevant tendon-to-bone tissue engineered constructs.  
The establishment of relevant animal models for translation of novel treatments is also a 
need, as researchers, providers and regulatory agencies should come up with a 
standardized animal model. In this regard, the definition of optimal rehabilitation periods 
and/or sex determining role on healing as variables of tendon-to-bone healing is of major 
importance. Preclinical data is still a crucial step toward clinical translation. However, 
suitable strategies for tendon-to-bone healing and/or regeneration require not only the 
use of graded biomaterials but also the ideal combination of cells, growth factors and 
culture conditions. Nevertheless, simple and ease handling constructs need to be 
developed and integrate appropriate biophysical, biological and biochemical signals to 
promote tissue integration and regeneration. Still, regulatory constraints and cost 
considerations will always be a concern while developing the best tissue engineering 
strategies. Strikingly, issues concerning the developed technologies, such as feasible 
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Table 1. Examples of co-culture systems for tendon-to-bone TERM applications 
 
 
 In vitro/ In 
vivo 
Cell types  
Culture 
system 





















2D using a 
spacer until 
confluent 
 After 14 days, 3 regions were distinguished: fibroblasts, 
fibroblasts plus osteoblasts (interface) and osteoblasts; 
 Presence of osteoblasts induced ALP activity and 
mineralization by fibroblasts; 
 Higher transcription levels of collagen type II, acan and 








 Fibroblasts-osteoblasts interaction in phase B of the scaffold 
(interface); 
 Higher ALP activity and mineralization by osteoblasts in 
phase C (hard tissue); 


















































































































































































































































 Fibroblasts  
(NIH 3T3 line) 







 The use of 3 mM betaglycerophosphate and 25 µg/mL 
ascorbic acid reduced fibroblasts mineralization while 
enhancing osteoblasts response; 











 Deposition of collagenous-rich matrix in all phases; 
 Higher deposition of collagen type III by fibroblasts (phase 
A); 
 Deposition of collagen types I, II and X phase B by 
chondrocytes; 


















































































































































































































































































 Gene expression of proteoglycans, collagen type I and II by 
BMSCs; 
 Conditioned medium of fibroblasts and osteoblasts 
decreased proliferation, glycosaminoglycan deposition and 
ALP activity by BMSCs 
 Conditioned media from fibroblasts-osteoblasts contact 
cultures promoted proteoglycan and TGF-ß1 synthesis and 
expression of SOX9 in BMSCs; 
 The presence of TGF-ß3 supplementation in co-cultured 




 Direct interaction between BMSCs with fibroblasts and 
osteoblasts resulted in gradual mineral deposition; 
 Up-regulation of collagen type II, SOX9 and aggrecan genes 


















































































































































































































































Abbreviations: ACAN – Aggrecan; ALP - Alkaline phosphatase; ASCs – Adipose-derived stem cells; BMSCs – Bone marrow stem cells; COMP – 












 Phenotype of single cultures maintained using an 
intermediate medium condition containing osteogenic and 
basal medium (1:1 ratio); 
 Higher expression of osteopontin and runx2 in co-culture in 
comparison with single cultures of pre-osteoblasts;  

































































































































































































































































Cell proliferation accompanied TGF-β1 temporal 
expression; Collagen remodeling, collagen types I and III 
production; TGF-β1 localized in the scar tissue and peaked 











Cell-specific expression: bFGF by fibroblast-like cells and 
ECs, IGF-1 by blood cells and ECs, PDGF by ECs, and TGF-β 
by blood cells; IGF-1 and TGF-β expressed during the 
inflammation period; Sequential peak expression of 











BMP-2 staining was more prominent at the tendon site at 
6 weeks while BMP-7 was mainly observed at the 
































































































































































































































































At week 1: up regulation of all growth factors during 
inflammation period; COMP peaked at 1 week; PDGF-B 
expression at weeks 1 and 8; TGF-β1 expression at weeks 
1, 2 and 8 in the midsubstance; BMP-12 moderately 
expressed at all time points; At 16 weeks, no expression of 













At week 1, FGF-2, BMP-2 and VEGF expression by 
fibroblasts and ECs at the interface; at week 3, VEGF 
expression by fibroblasts, FGF-2, and VEGF expression by 
osteoblasts; BMPs stained in fibroblasts and osteoblasts at 
the interface; At week 6, bFGF and VEGF in fibroblasts and 
osteoblasts at the interface; At week 12, bFGF and BMP-7 
residually expressed by fibroblasts and osteoblasts at the 
interface; BMP-2 and BMP-7 in osteoblasts – expression 



















































































































































































































































Abbreviations: bFGF – basic fibroblast growth factor; IGF-1 - insulin-like growth factor 1; PDGF – Platelet-derived growth factor; TGF-β – 
Transforming growth factor beta; BMP – Bone morphogenetic protein; CTGF – Connective tissue growth factor; COMP – Cartilage oligomeric 
matrix protein.  


















































































































































































































































Table 3. In vivo studies using growth factors for tendon-to-bone healing. 
Growth 
factors 






Bone Morphogenetic Proteins (BMPs) 
rhBMP-2 






Phase I: 2 weeks 
Phase II: 1, 2 and 8 weeks 
Rabbi
t 
Phase I: BMP-2 
increased bone 
width in a dose 
dependent way; 



































































































































































































































































rhBMP-2 Achilles tendon repair 
Local 
injection  
Experiment I: 1, 2, 3 and 4 
weeks 





































































































































































































































































tendon after 2 






















































































































































































































































































rhBMP-2 led to 
greater 
maximum 
tensile load and 
























































































































































































































































Phase II:  

































































































































































































































































bone nodules in 
treated groups. 
BMP-2 Patellar repair 
Fibrin glue  
and collagen 
gel 














higher failure to 
load in fibrin 
glue with BMP-













































































































































































































































































































































































































































































































































scar tissue zone 




















































































































































































































































rhBMP-2 Chronic rotator cuff tear  
Dermal 
patch 


















After 8 weeks, 
higher cell 
penetration 
near the host 
























































































































































































































































rhBMP-2 Rotator cuff repair 
β-TCP  
material 
































































































































































































































































































































































































































































































































































Achilles tendon repair Suture 



































































































































































































































































repair in the 
presence of 
collagen type II. 
Cartilage-derived Morphogenetic Proteins (CDMPs) 
CDMP-2 Supraspinatus Tendon Repair Sutures 
2, 3, 4  
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weeks 4 and 6; 
Significantly 
higher load to 
failure at week 
4. 
Transforming Growth Factors (TGF) 
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Fibroblast Growth Factor (FGF) 
bFGF Chronic Rotator cuff tear 
PLGA fibrous 
membranes 
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At 2 weeks, 
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At gene level, 






























































































































































































































































4 to 12 weeks; 
Sox-9 (Sox9) 
significantly up-


























































































































































































































































strength at 6 
and 12 weeks. 












Experiment II:  




observed at ≥ 6 
weeks 
postoperatively; 




observed in the 
repair site in 
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Granulocyte-colony stimulating factor (G-CSF) 





3 and 9 weeks Rat 
Higher amounts 
of G-CSF (10 μg) 
resulted in a 
significant 
increase in 























































































































































































































































amounts (1 μg) 
and placebo; No 
differences 
between the 
tested groups in 
the mean load 
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Abbreviations: ALP – Alkaline phosphatase; BMP-2/7 - Bone Morphogenetic Protein 2/7; CDMP-2 – Cartilage-derived morphogenetic proteins; 
COL1A2 – Collagen type II; FGF – Fibroblast growth factor 2; G-CSF – Granulocyte-colony stimulating factor; GDF-5 – Growth differentiation 













ones at both 12 



















































































































































































































































co-glycolic acid); SCX – scleraxis; rhBMP – recombinant human bone morphogenetic protein; TGF- β1/3 – Transforming growth factor – beta 






























































































































































































































































Injection into the bone 
tunnel 
 Improved tissue integration and 








Local injection of PRP 
gel 
 Formation of a transition zone 
with moderate collagen fiber 
organization after 3 months, no 
chondrocytes were observed; 
 Complete healing (not observed in 
controls); 
 Proteoglycan expression; 








Injection (pipped) onto 
tendon-bone 
approximation 
 Increased acute cellular 
inflammation at day 7; 
 Enhanced biomechanical 
properties at day 21; 
[152] 

















































































































































































































































 Better collagen fiber organization 
and alignment at day 21 
Adult male 
Wistar rats 
PRP Local injection 
 Reparative fibrous and granulation 
tissue between tendon and bone 
tissue, in comparison to acute 
inflammatory infiltrates and 
initiation of scar formation in 
controls; 
 Higher maximum load and stiffness 







PRP infused into an 
absorbable hemostatic 
gelatin sponge 
 Improved biomechanical 
properties in comparison to no 
repair/primary repair controls, but 








Suture sprayed with PRP 
Suture sprayed with PRP 
+ bioactive glass (BG) 
powder 
 Higher mean failure load after 6 
and 12 weeks – highest for PRP + 
BG group; 



























































































































































































































































PRP in combination with 
ACL grafts prepared by 
braid-twist canine small 
intestinal submucosa 
(SIS) 
 Fibrous and vascularized tissue 
formed around SIS graft in SIS+PRP 
group; 
 More adhesions in SIS control; 
 Lower mechanical properties in 
SIS+PRP group, compared to SIS 
alone; 
 Improved cellular response, 
chondrocyte cell infiltration, and 










Hamstring tendon graft 
wrapped with PRP 
immobilized in fibrin glue 
 Aligned connective tissue, newly 
formed bone and cartilage at the 
tendon-to-bone interface after 8 
weeks; 
 Formation of mineralized tissue at 








































































































































































































































































































































































































































































































Figure 1. Schematic representation of biological, biophysical and biochemical 



















































































































































































































































Figure 2. Structure and composition of tendon-to-bone interface. Values of mean fiber 



















































































































































































































































Figure 3. The structure and collagen composition of tendon-to-bone attachment. (A) 
Confocal reflection microscopy image of enthesis cryosection demonstrating that tendon 
fibers unravel into thinner fibers at the interface preceding bone attachment. Scale bar, 
250 µm. (B) Confocal image immunostained for collagen type I (magenta) and collagen 
type II (cyan) showing a fiber composition change at ~500 m before reaching the bone. 




















































































































































































































































Figure 4. Co-culture setup of fibroblasts and osteoblasts and effect on alkaline 
phosphatase activity. (A) Co-culture system using a hydrogel divider; (B) Light microscopy 
and fluorescence images of the three different regions. Fibroblasts are shown in red and 
osteoblasts in green after 14 days of culture. (C) Normalized ALP activity over time in 
culture revealed an increase in ALP levels in co-culture. * denotes significance at p<0.05. 
(D) Fast-Blue staining for ALP of the co-cultured osteoblasts and the correspondent control 
groups (fibroblasts and osteoblasts) and (E) fluorescence tracking of osteoblasts (CM-Dil) 
demonstrated an ALP positive staining of fibroblasts in the co-cultured well. Adapted from 



















































































































































































































































Figure 5. Production setups of 3D cylindrical scaffold and osteotendinous scaffold. (A) 
Schematics of an electrospinning dual-motor collector for the production of random-
aligned-random PCL fibrous scaffolds for ligament to bone application. Scale bars: 10 um 
and 100 nm. Reproduced from Lin et al. [170] with permission from The Royal Society of 
Chemistry. (B) Schematic setup of the multicomparted osteotendinous scaffolds 
production with distinct regions of pore anisotropy and mineral content. Scanning electron 
micrographs showing an isotropic porosity in the mineralized area (CGCaP) and aligned 
porosity in the tendinous region (CG). Scale bars, 200 µm. Confocal micrograph of the 
scaffold stained with AlexaFluor 488-streptavidin conjugate in the osseous (CGCaP) part 
and AlexaFluor 594-BSA conjugate in the tendinous (CG) compartment. Scale bar, 1 mm. 
Adapted from Caliari et al. [172]. All rights reserved © 2015 WILEY‐VCH Verlag GmbH & 
Co. KGaA, Weinheim. 
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